LSP raises Europe’s largest life sciences VC fund

Amsterdam-based firm Life Sciences Partners held the final close of its flagship fund LSP 7, which at €1 billion ($1.3 billion) was the largest life sciences venture capital strategy on record.

The fund aims to invest in companies developing new drug therapies and medical technologies in a bid to ensure the scientific innovations ultimately benefit patients.

LSP raised €850 million for LSP 7 in November and announced plans to join forces with Swedish private equity giant EQT.

The Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.

Monthly subscriptions and discounted corporate plans for up to 100 members also available.

Related Articles

Back to top button

Start Your Days in the Know


Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!